Literature DB >> 11225704

Development of a personal dosimetry system based on optically stimulated luminescence of alpha-Al2O3:C for mixed radiation fields.

S Y Lee1, K J Lee.   

Abstract

To develop a personal optically stimulated luminescence (OSL) dosimetry system for mixed radiation fields using alpha-Al2O3:C, a discriminating badge filter system was designed by taking advantage of its optically stimulable properties and energy dependencies. This was done by designing a multi-element badge system for powder layered alpha-Al2O3:C material and an optical reader system based on high-intensity blue light-emitting diode (LED). The design of the multielement OSL dosimeter badge system developed allows the measurement of a personal dose equivalent value Hp(d) in mixed radiation fields of beta and gamma. Dosimetric properties of the personal OSL dosimeter badge system investigated here were the dose response, energy response and multi-readability. Based on the computational simulations and experiments of the proposed dosimeter design, it was demonstrated that a multi-element dosimeter system with an OSL technology based on alpha-Al2O3:C is suitable to obtain personal dose equivalent information in mixed radiation fields.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11225704     DOI: 10.1016/s0969-8043(00)00302-x

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  3 in total

1.  MR-safe personal radiation dosimeters.

Authors:  E Tchistiakova; A Kim; W Y Song; G Pang
Journal:  J Appl Clin Med Phys       Date:  2017-06-06       Impact factor: 2.102

2.  Recent developments of optically stimulated luminescence materials and techniques for radiation dosimetry and clinical applications.

Authors:  A S Pradhan; J I Lee; J L Kim
Journal:  J Med Phys       Date:  2008-07

3.  Optically stimulated luminescent dosimetry for high dose rate brachytherapy.

Authors:  Christopher Jason Tien; Robert Ebeling; Jessica R Hiatt; Bruce Curran; Edward Sternick
Journal:  Front Oncol       Date:  2012-08-06       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.